Johanna Corbin, senior vice president and head of intellectual property and litigation at AbbVie, led a delegation to the Shanghai Intellectual Property Administration on Oct 27 for talks with director-general Zhu Qigao. Deputy director-general Yu Chen also attended.
AbbVie delegation is welcomed by SIPA officials. [Photo/WeChat ID: Shanghai_IPA]
Zhu welcomed the delegation and recognized AbbVie's contributions to Shanghai's biopharmaceutical innovation and industrial development. He said Shanghai attaches great importance to IP protection and respects innovation, and is committed to providing high-quality protection and services to all market entities, including foreign-invested enterprises.
Yu briefed the delegation on the administration's responsibilities and recent work, highlighting IP issues in the pharmaceutical sector. He expressed hope for stronger exchanges with AbbVie and with Interpat, a global non-profit for biopharma IP protection.
Corbin thanked the administration for its support and for IP protection for AbbVie's operations and development in Shanghai. She also expressed her willingness to strengthen communication and cooperation with the administration.
The two sides exchanged views on issues of concern to the international pharmaceutical industry, including biopharmaceutical patent protection and drug patent linkage.
